| scholarly article | Q13442814 |
| P2093 | author name string | P S Harper | |
| A L Jones | |||
| J D Wood | |||
| J M Boutell | |||
| P433 | issue | 3 | |
| P304 | page(s) | 371-378 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Huntingtin interacts with cystathionine beta-synthase | |
| P478 | volume | 7 |
| Q28141695 | Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin |
| Q37109961 | Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins |
| Q33703905 | Are there multiple pathways in the pathogenesis of Huntington's disease? |
| Q34132509 | Brain hydrogen sulfide is severely decreased in Alzheimer's disease |
| Q47304813 | Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases |
| Q34460105 | Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? |
| Q45299047 | Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding |
| Q42697075 | Effects of dietary supplementation of high-dose folic acid on biomarkers of methylating reaction in vitamin B(12)-deficient rats |
| Q25257631 | Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease |
| Q35764318 | Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans |
| Q33826159 | Huntingtin localisation studies - a technical review |
| Q57839949 | Huntingtin proteolysis in Huntington disease |
| Q45296265 | Huntingtin: a single bait hooks many species |
| Q34248391 | Hydrogen sulfide as a gasotransmitter |
| Q34155574 | Hydrogen sulfide as a neuromodulator. |
| Q38513243 | Hyperhomocysteinemia: Impact on Neurodegenerative Diseases |
| Q24290297 | Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein |
| Q34158010 | Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases |
| Q38213862 | Involuntary movements due to vitamin B12 deficiency |
| Q33921816 | Isolation of a 40-kDa Huntingtin-associated protein |
| Q30640638 | Localization of rabbit huntingtin using a new panel of monoclonal antibodies |
| Q34408222 | Modeling Huntington's disease in cells, flies, and mice |
| Q34711201 | Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior |
| Q33304630 | Mutant huntingtin can paradoxically protect neurons from death |
| Q35862438 | Novel structural arrangement of nematode cystathionine β-synthases: characterization of Caenorhabditis elegans CBS-1. |
| Q38589017 | Oxygen tension, H2S, and NO bioavailability: is there an interaction? |
| Q63951832 | Plans for HDBase—a research community website for Huntington's Disease |
| Q40900388 | Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network |
| Q28821025 | Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases |
| Q24676589 | The localization and interactions of huntingtin |
| Q24293871 | The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease |
| Q34216757 | The selective vulnerability of nerve cells in Huntington's disease |
| Q34001953 | Transcriptional dysregulation in Huntington's disease |
Search more.